Celltrion, Inc.
068270.KS
Price:
$195100
Market Cap:
$42.98T
Celltrion, Inc., together with its subsidiaries, develops and produces therapeutics based on proteins including oncology treatment drugs in South Korea. The company markets Remsima, Truxima, and Herzuma products; generic pharmaceuticals; covid-19 test kits. Its antibody biosimilar pipeline includes CT-P39 for the treatment of asthma and urticaria that is in phase 1 clinical trial; CT-P17 for the treatment of rheumatoid arthritis, psoriatic arthritis, and IBD, which is in phase 3 clinical trial; CT-P16 for the treatment of metastatic colorectal cancer and breast cancer that is in phase 3 clinical trial; CT-P41 for the treatment of osteoporosis and bone loss, which is in phase 1 clinical trial...[Read more]
Industry
Biotechnology
IPO Date
2005-07-19
Stock Exchange
KSC
Ticker
068270.KS
PE Ratio
[46.12]
ROE
[2.90%]
Current Ratio
[1.43]
Dividend Yield
[0.35%]
Enterprise Value
[44.88T]
Dividend History
068270.KS Dividend History Overview
Dividends are a key part of long-term returns for investors, and Celltrion, Inc. (068270.KS) has a track record worth reviewing. Looking at dividend history for 068270.KS gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2024-12-27
Dividend Yield
0.35%
Annual Dividend
$714.29
P/E Ratio
46.12
Payout Ratio
0.31
Dividend per Share
$678.57
EPS
4.23K
| Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
|---|---|---|---|---|
| 2024-12-27 | $714.28572 | $678.571434 | 2025-04-01 | |
| 2023-12-27 | $525 | $500 | 2024-04-23 | |
| 2022-12-28 | $375 | $375 | 2023-04-24 | |
| 2021-12-29 | $750 | $686.8132 | 2022-04-22 | |
| 2012-12-27 | $12.9 | $18.66136 | ||
| 2011-12-28 | $100 | $83.86187 | ||
| 2010-12-29 | $75 | $59.90133 | ||
| 2007-12-27 | $50 | $41.93094 | ||
| 2006-12-27 | $50 | $41.93094 |
Celltrion, Inc. (068270.KS) Dividend History Chart
The table below shows Celltrion, Inc. (068270.KS) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
Celltrion, Inc. (068270.KS) Dividend Growth
Celltrion, Inc. (068270.KS) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Other Popular Dividend Stocks
Check out the dividend history of other popular stocks:
| Stock name | Dividend yield |
|---|
Track & Identify Dividend Stocks
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like Celltrion, Inc. (068270.KS) without the pain and hassle of copy pasting data.
Frequently asked questions❓
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is 068270.KS’s dividend yield?
What is the difference between regular and special dividends?
Has 068270.KS increased its dividends over time?
Why might dividend history data be delayed?
How often does 068270.KS pay dividends?
What factors impact 068270.KS's dividend payments?
Can dividends change over time?
What is 068270.KS’s next dividend date?